Sorafenib-induced acute myocardial infarction due to coronary artery spasm
Authors:
- Shuichi OshimaSOShuichi Oshima
- Katsuo NodaKNKatsuo Noda
- Hironobu FukushimaHFHironobu Fukushima
- Izumi TaniguchiITIzumi Taniguchi
- Shinichi NakamuraSNShinichi Nakamura
- Makoto ShonoMSMakoto Shono
- Hisao OgawaHOHisao Ogawa
- 1 December 2009
- journal article
- case report
- Published by Elsevier in Journal of Cardiology
- Vol. 54 (3) , 512-515
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signalingMolecular Cancer Therapeutics, 2008
- Provoked Coronary Spasm Predicts Adverse Outcome in Patients With Acute Myocardial InfarctionJACC, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Coronary artery spasm—Clinical features, diagnosis, pathogenesis, and treatmentJournal of Cardiology, 2008
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin PhosphatasePhysiological Reviews, 2003
- Involvement of Src Family Protein Tyrosine Kinases in Ca 2+ Sensitization of Coronary Artery Contraction Mediated by a Sphingosylphosphorylcholine-Rho-Kinase PathwayCirculation Research, 2002
- Myocardial Infarction with Normal Coronary Arteries: The Pathologic and Clinical PerspectivesAngiology, 2001
- Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertensionNature, 1997
- Effect of acetylcholine on the highly stenotic coronary artery: Difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related arteryJACC, 1992